COPD News

Factors such as advanced age and recent severe exacerbation may predict opioid-related pulmonary events in older adults with COPD, according to a study published in Annals of the American Thoracic Society.

Adding ensifentrine to tiotropium demonstrated clinically important improvements in lung function and quality of life at 4 weeks in patients with moderate to severe COPD, according to a new study.

In certain patients with COPD, regular, low-dose, oral sustained-release morphine treatment for 4 weeks improved several disease outcomes without causing respiratory adverse effects, a randomized clinical trial showed.

Doubling the inhaled corticosteroid dose and adding umeclidinium to inhaled corticosteroid/long-acting beta agonist in a single-inhaler triple therapy improved outcomes in inadequately controlled asthma, data from the CAPTAIN study show.

In a large-scale study, ED visits for thunderstorm-related acute respiratory illnesses were increased in older U.S. adults, including those with asthma and COPD, according to findings published in JAMA Internal Medicine.

Former and current smokers living in high-poverty neighborhoods may have an increased risk for adverse respiratory effects of ozone exposure.

The Healio editors have compiled a list of the most-read pulmonology news published in July.

The FDA has approved triple inhaled therapy for maintenance treatment of patients with COPD, according to a press release from AstraZeneca.

Neutrophil to lymphocyte ratio may be a clinically relevant biomarker associated with increased risk for COPD and lung function impairment, according to data published in JAMA Network Open.

A team of researchers created a prognostic nomogram that accurately predicted risk factors associated with mortality in hospitalized patients with COVID-19 based on individual features, according to data published in Chest.